Variant report

Variant	nsv1001923
Chromosome Location	chr4:69678883-69737036
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:69730036-69730982	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:69680934-69681903	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:69683102-69684193	HepG2	liver:	n/a	chr4:69683103-69683119
4	ARID3A	chr4:69729954-69730646	K562	blood:	n/a	n/a
5	ARID3A	chr4:69736479-69738539	HepG2	liver:	n/a	n/a
6	ATF1	chr4:69730145-69730592	K562	blood:	n/a	n/a
7	ATF3	chr4:69730144-69730551	K562	blood:	n/a	n/a
8	BHLHE40	chr4:69681403-69681779	HepG2	liver:	n/a	n/a
9	BHLHE40	chr4:69730154-69730623	K562	blood:	n/a	n/a
10	CBX3	chr4:69710563-69710928	K562	blood:	n/a	n/a
11	CBX3	chr4:69730066-69730440	K562	blood:	n/a	n/a
12	CCNT2	chr4:69730149-69730560	K562	blood:	n/a	n/a
13	CEBPB	chr4:69736814-69737153	HepG2	liver:	n/a	chr4:69736964-69736975
14	CEBPB	chr4:69684002-69684205	A549	lung:	n/a	chr4:69684140-69684151 chr4:69684141-69684152
15	CEBPB	chr4:69736878-69737053	HepG2	liver:	n/a	chr4:69736964-69736975
16	CEBPB	chr4:69730120-69730588	HepG2	liver:	n/a	n/a
17	CEBPB	chr4:69678841-69679067	HepG2	liver:	n/a	n/a
18	CEBPB	chr4:69730091-69730606	HepG2	liver:	n/a	n/a
19	CEBPB	chr4:69685580-69685738	A549	lung:	n/a	chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685613-69685624 chr4:69685612-69685623
20	CEBPB	chr4:69685586-69685776	H1-hESC	embryonic stem cell:	n/a	chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685613-69685624 chr4:69685612-69685623
21	CEBPB	chr4:69683737-69684291	HepG2	liver:	n/a	chr4:69684140-69684151 chr4:69684141-69684152
22	CEBPB	chr4:69712445-69712703	HepG2	liver:	n/a	chr4:69712549-69712560
23	CEBPB	chr4:69736853-69737111	HepG2	liver:	n/a	chr4:69736964-69736975
24	CEBPB	chr4:69685477-69685793	HepG2	liver:	n/a	chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685613-69685624 chr4:69685612-69685623
25	CEBPB	chr4:69685485-69685717	K562	blood:	n/a	chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685613-69685624 chr4:69685612-69685623
26	CEBPB	chr4:69730156-69730448	HepG2	liver:	n/a	n/a
27	CEBPB	chr4:69681686-69681867	HepG2	liver:	n/a	n/a
28	CEBPB	chr4:69684063-69684187	K562	blood:	n/a	chr4:69684140-69684151 chr4:69684141-69684152
29	CEBPB	chr4:69736848-69737078	A549	lung:	n/a	chr4:69736964-69736975
30	CEBPB	chr4:69730044-69730628	K562	blood:	n/a	n/a
31	CEBPB	chr4:69736927-69737111	K562	blood:	n/a	chr4:69736964-69736975
32	CEBPB	chr4:69685492-69685778	IMR90	lung:	n/a	chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685612-69685625 chr4:69685613-69685624 chr4:69685612-69685623
33	CEBPB	chr4:69684015-69684280	IMR90	lung:	n/a	chr4:69684140-69684151 chr4:69684141-69684152
34	CEBPB	chr4:69681485-69681922	HepG2	liver:	n/a	n/a
35	CEBPB	chr4:69736614-69737153	HepG2	liver:	n/a	chr4:69736964-69736975
36	CEBPB	chr4:69726843-69727112	HepG2	liver:	n/a	chr4:69726927-69726938
37	CEBPB	chr4:69730188-69730552	HepG2	liver:	n/a	n/a
38	CEBPB	chr4:69730223-69730555	K562	blood:	n/a	n/a
39	CEBPB	chr4:69730150-69730642	K562	blood:	n/a	n/a
40	CEBPD	chr4:69730019-69730648	K562	blood:	n/a	n/a
41	CEBPD	chr4:69736834-69737096	HepG2	liver:	n/a	n/a
42	CEBPD	chr4:69681639-69681887	HepG2	liver:	n/a	n/a
43	CEBPD	chr4:69730054-69730667	K562	blood:	n/a	n/a
44	CREB1	chr4:69730084-69730687	K562	blood:	n/a	n/a
45	CREB1	chr4:69736425-69736957	HepG2	liver:	n/a	n/a
46	CTCF	chr4:69683829-69683943	Lung_OC	lung:	n/a	n/a
47	CTCF	chr4:69681974-69682009	Pancreas_OC	pancreas:	n/a	n/a
48	CTCF	chr4:69731460-69731610	MCF-7	breast:	n/a	n/a
49	CTCF	chr4:69692957-69692997	Kidney_OC	kidney:	n/a	n/a
50	CTCF	chr4:69713220-69713370	GM12872	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:69681824-69681874	HCT-116	colon:	n/a
2	chr4:69681824-69681874	GM12878	blood:	n/a
3	chr4:69681824-69681874	BJ	skin:	n/a
4	chr4:69681824-69681874	AG09309	skin:	n/a
5	chr4:69681824-69681874	PFSK-1	brain:	n/a
6	chr4:69681824-69681874	ECC-1	luminal epithelium:	n/a
7	chr4:69681824-69681874	BE2_C	brain:	n/a
8	chr4:69681824-69681874	A549	lung:	n/a
9	chr4:69681824-69681874	PANC-1	pancreas:	n/a
10	chr4:69681824-69681874	HCPEpiC	choroid plexus:	n/a
11	chr4:69681824-69681874	HAEpiC	amniotic membrane:	n/a
12	chr4:69681824-69681874	NT2-D1	testis:	n/a
13	chr4:69681824-69681874	AG04449	skin:	fetal
14	chr4:69681824-69681874	K562	blood:	n/a
15	chr4:69681824-69681874	HCF	heart:	n/a
16	chr4:69681824-69681874	Caco-2	colon:	n/a
17	chr4:69681824-69681874	HUVEC	blood vessel:	n/a
18	chr4:69681824-69681874	ProgFib	skin:	n/a
19	chr4:69681824-69681874	GM06990	blood:	n/a
20	chr4:69681824-69681874	SKMC	muscle:	n/a
21	chr4:69681824-69681874	T-47D	breast:	n/a
22	chr4:69681824-69681874	GM12892	blood:	n/a
23	chr4:69681824-69681874	Hepatocyte	liver:	n/a
24	chr4:69681824-69681874	AoSMC	blood vessel:	n/a
25	chr4:69681824-69681874	LNCaP	prostate:	n/a
26	chr4:69681824-69681874	GM12891	blood:	n/a
27	chr4:69681824-69681874	U87	brain:	n/a
28	chr4:69681824-69681874	ovcar-3	ovarian:	n/a
29	chr4:69681824-69681874	CMK	blood:	n/a
30	chr4:69681824-69681874	AG09319	gingival:	n/a
31	chr4:69681824-69681874	SK-N-MC	brain:	n/a
32	chr4:69681824-69681874	NHBE	bronchial:	n/a
33	chr4:69681824-69681874	H1-hESC	embryonic stem cell:	embryo
34	chr4:69681824-69681874	RPTEC	kidney:	n/a
35	chr4:69681824-69681874	SAEC	small airway:	n/a
36	chr4:69681824-69681874	HepG2	liver:	n/a
37	chr4:69681824-69681874	HNPCEpiC	eye:	n/a
38	chr4:69681824-69681874	HL-60	blood:	n/a
39	chr4:69681824-69681874	GM19239	blood:	n/a
40	chr4:69681824-69681874	HCM	heart:	n/a
41	chr4:69681824-69681874	IMR90	lung:	fetal
42	chr4:69681824-69681874	NHDF-neo	bronchial:	n/a
43	chr4:69681824-69681874	HPAEpiC	pulmonary alveolar:	n/a
44	chr4:69681824-69681874	PrEC	prostate:	n/a
45	chr4:69681824-69681874	HEEpiC	esophagus:	n/a
46	chr4:69681824-69681874	NH-A	brain:	n/a
47	chr4:69681824-69681874	HEK293	kidney:	embryo
48	chr4:69681824-69681874	SK-N-SH	brain:	n/a
49	chr4:69681824-69681874	AG10803	skin:	n/a
50	chr4:69681824-69681874	Hela-S3	cervix:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:69590462..69592610-chr4:69729563..69731579,3	MCF-7	breast:
2	chr4:69728116..69730348-chr4:69734174..69736815,2	K562	blood:
3	chr4:69730313..69732082-chr4:69762356..69764791,2	MCF-7	breast:
4	chr4:69730473..69734007-chr4:69770100..69773388,5	MCF-7	breast:
5	chr4:69728116..69730348-chr4:69734174..69736815,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT2B10-1	chr4:69679713-69680445	NONHSAT096742

Variant related genes	Relation type
ENSG00000249235	TF binding region
ENSG00000251236	TF binding region
UGT2B10	TF binding region
ENSG00000251424	TF binding region
ENSG00000249235	CpG island
ENSG00000251236	CpG island
UGT2B10	CpG island
ENSG00000251424	CpG island
ENSG00000272626	chromatin interactions

Extended variants
information (count: 2231 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:2231 , 50 per page) page: 1 2 3 4 5 6 7 ... 45

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs187438329	chr4:69678900-69678901	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs294774	chr4:69678930-69678931	Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs7671312	chr4:69678943-69678944	Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs75940413	chr4:69678948-69678949	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs77906201	chr4:69678963-69678964	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs75791502	chr4:69678967-69678968	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs527440294	chr4:69679065-69679066	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs116529493	chr4:69679113-69679114	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs111968814	chr4:69679175-69679176	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs529994339	chr4:69679189-69679190	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs835308	chr4:69679220-69679221	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs201101009	chr4:69679244-69679245	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs117719629	chr4:69679252-69679253	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs538748696	chr4:69679257-69679258	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs141869426	chr4:69679258-69679259	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs114969195	chr4:69679310-69679311	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs377224335	chr4:69679319-69679320	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs545655358	chr4:69679343-69679344	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs143792683	chr4:69679355-69679356	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs563043660	chr4:69679442-69679443	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs536532161	chr4:69679462-69679463	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs28430496	chr4:69679497-69679498	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs12644440	chr4:69679570-69679571	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs192204561	chr4:69679574-69679575	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs545491362	chr4:69679576-69679577	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs565416581	chr4:69679582-69679583	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs184638948	chr4:69679594-69679595	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs201604393	chr4:69679603-69679604	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs541253925	chr4:69679618-69679619	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs561047357	chr4:69679627-69679628	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs187904956	chr4:69679670-69679671	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs542215285	chr4:69679689-69679690	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs192703144	chr4:69679695-69679696	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs563298457	chr4:69679698-69679699	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs35525464	chr4:69679729-69679730	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
36	rs66701588	chr4:69679735-69679736	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
37	rs113242232	chr4:69679748-69679749	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
38	rs552141839	chr4:69679760-69679761	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
39	rs565485977	chr4:69679761-69679762	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
40	rs533572503	chr4:69679765-69679766	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
41	rs184362104	chr4:69679767-69679768	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
42	rs547622210	chr4:69679774-69679775	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
43	rs111806419	chr4:69679809-69679810	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
44	rs567489360	chr4:69679817-69679818	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
45	rs189688309	chr4:69679881-69679882	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
46	rs34183546	chr4:69679883-69679884	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
47	rs548074574	chr4:69679942-69679943	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
48	rs150240967	chr4:69679951-69679952	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
49	rs137949899	chr4:69679956-69679957	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
50	rs538703273	chr4:69680016-69680017	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Graft versus host disease	20877625	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Osteoporosis	20877625	CNVD
Osteoporosis	19737800	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Glioblastoma multiforme	21138945	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Oral cancer	21386901	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
early-passage human iPS cells	21368824	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	23813976	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:137 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:69678400-69679200	Enhancers	HepG2	liver
2	chr4:69679200-69679600	Weak transcription	HepG2	liver
3	chr4:69679600-69681800	Enhancers	HepG2	liver
4	chr4:69680800-69681200	Enhancers	Liver	Liver
5	chr4:69681000-69682600	Enhancers	A549	lung
6	chr4:69681200-69681800	Weak transcription	Liver	Liver
7	chr4:69681400-69682000	Enhancers	iPS-18 Cell Line	embryonic stem cell
8	chr4:69681600-69684000	Enhancers	HUES48 Cell Line	embryonic stem cell
9	chr4:69681800-69682200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr4:69681800-69682600	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr4:69681800-69682600	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr4:69681800-69683000	Enhancers	HUES64 Cell Line	embryonic stem cell
13	chr4:69681800-69683000	Flanking Active TSS	HepG2	liver
14	chr4:69681800-69684600	Active TSS	Liver	Liver
15	chr4:69682000-69682200	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
16	chr4:69682200-69682400	Enhancers	iPS-18 Cell Line	embryonic stem cell
17	chr4:69682200-69682800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr4:69682400-69682600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
19	chr4:69682400-69682800	Enhancers	iPS-20b Cell Line	embryonic stem cell
20	chr4:69682400-69682800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
21	chr4:69682600-69683200	Enhancers	iPS-18 Cell Line	embryonic stem cell
22	chr4:69682600-69683600	Weak transcription	HUES6 Cell Line	embryonic stem cell
23	chr4:69682600-69683600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
24	chr4:69682600-69683800	Weak transcription	A549	lung
25	chr4:69682800-69684200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
26	chr4:69683000-69683400	Weak transcription	HUES64 Cell Line	embryonic stem cell
27	chr4:69683000-69683600	Active TSS	HepG2	liver
28	chr4:69683200-69683600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
29	chr4:69683400-69684800	Enhancers	HUES64 Cell Line	embryonic stem cell
30	chr4:69683600-69683800	Flanking Active TSS	HepG2	liver
31	chr4:69683600-69684200	Enhancers	iPS-15b Cell Line	embryonic stem cell
32	chr4:69683600-69684200	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr4:69683800-69684000	Enhancers	HUES6 Cell Line	embryonic stem cell
34	chr4:69683800-69684000	Enhancers	A549	lung
35	chr4:69683800-69684000	Active TSS	HepG2	liver
36	chr4:69684000-69684200	Flanking Active TSS	HepG2	liver
37	chr4:69684200-69684600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
38	chr4:69684200-69686000	Enhancers	HepG2	liver
39	chr4:69684600-69686000	Flanking Active TSS	Liver	Liver
40	chr4:69686000-69686600	Enhancers	Liver	Liver
41	chr4:69686000-69688000	Weak transcription	HepG2	liver
42	chr4:69686600-69686800	Flanking Active TSS	Liver	Liver
43	chr4:69686800-69687000	Enhancers	Liver	Liver
44	chr4:69687000-69687200	Flanking Active TSS	Liver	Liver
45	chr4:69687200-69688600	Weak transcription	Liver	Liver
46	chr4:69688000-69690200	Enhancers	HepG2	liver
47	chr4:69688600-69689200	Genic enhancers	Liver	Liver
48	chr4:69689200-69693800	Weak transcription	Liver	Liver
49	chr4:69689800-69690000	Enhancers	Pancreas	Pancrea
50	chr4:69690200-69690600	Weak transcription	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links